Skip to content
Search

Latest Stories

NHS: Dr. Sue Mann appointed as the inaugural National Clinical Director for Women's Health

NHS: Dr. Sue Mann appointed as the inaugural National Clinical Director for Women's Health

Dr. Mann's appointment coincides with the recruitment of six other National Clinical Directors

The National Health Service (NHS) has made a historic decision to appoint Dr. Sue Mann as its inaugural National Clinical Director for Women’s Health, marking a significant step forward in improving women’s healthcare services across England.


The announcement follows the recent confirmation of 18 National Clinical Directors as part of the 2024 cohort and coincides with six other recruitments.

Dr. Mann, a distinguished consultant and lead for women’s health in City and Hackney, North East London, brings with her a wealth of experience and expertise to this pivotal role.

Her responsibilities will include spearheading the strategy and facilitating the establishment of women’s health hubs throughout England to address various women's health concerns comprehensively, including menstrual health services and menopause assessment and treatment.

Additionally, Dr. Mann will collaborate with local care systems to establish a network of Women’s Health Champions, composed of senior leaders dedicated to advancing women’s health initiatives at the grassroots level.

Dr. Mann's previous contributions to women’s healthcare, such as pioneering Women’s Health Hubs and Virtual Group Consultations, highlight her innovative approach and dedication to improving healthcare delivery for women.

These initiatives, which are featured in the Women’s Health Strategy, underscore Dr. Mann's capacity to drive positive change in the field.

Expressing her enthusiasm for the new role, Dr. Mann emphasized her commitment to addressing the challenges faced by women in accessing quality healthcare:

"Having spent my career researching, treating, and developing policy and initiatives focused on women’s health, I have seen firsthand the challenges many women face, as well as the progress that has been made through better understanding and awareness of conditions affecting women."

Government officials have praised Dr. Mann's appointment as a significant step towards achieving the objectives outlined in the Women’s Health Strategy.

Minister for Women’s Health Strategy Maria Caulfield highlighted the pivotal role Dr. Mann will play in ensuring women's needs remain central to decision-making processes.

Dr. Mann's appointment signifies a significant milestone in the NHS's ongoing efforts to prioritize women’s health and underscores its commitment to delivering equitable and inclusive healthcare services for all.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less